The healthcare industry is changing and we have the breadth of expertise to help you evolve with it.

Comprehensive service offerings at every point in the product life cycle.

RAMS

A platform of digital products to improve, simplify and automate RA/QA activities

OPUS

Emergo by UL's new human factors tool - provides training, tools, and resources.

The latest industry news and insights from our global team.

RADAR : Market Access Newsletter

Stay informed with the most read RA/QA medical device newsletter.

TalkingPoints : Human Factors Newsletter

TalkingPoints is a round-up of news, insights, and resources about human factors and usability for medical devices, IVDs, combination products, and more.

Learn from our experts through live events.

Our global consulting team works from 20+ offices on six continents.

2021 Medical Device Industry Outlook

Read the results of our 2021 Medical Device Industry Outlook Survey, based on responses from 1600 professionals.

Doctor using a medical app on a smartphone to examine patient

Our intention in conducting this survey is to provide a high-level snapshot of the industry’s current state, as well as its prospects over the coming year.

Download Survey

Global Medical Device Industry Outlook for 2021

2.18 MB

Download

2021-industry-outlook-survey.pdf

Related services

Certificate of Free Sale (CFS) for Medical Device Exports

Person taking notes on a clipboard while someone tests a medical device

Obtaining a Medical Device CFG (Certificate to Foreign Government) from FDA

Photo of flags from around the world flying in the wind

Customized Regulatory Pathway Reports for Smaller International Markets

Image Of Medical Ventilator. Hospital Respiratory Ventilation. Patient Life Saving Machine

ISO 14971 Risk Management Training for Medical Device Companies

To access the results of our 2021 Medical Device Industry Outlook Survey, please fill out the form below:

Please wait…

You are leaving the Emergo by UL website for an external site. Emergo by UL structures this activity to be distinct and separate from its conformity assessment bodies.